Pakistan Begins Phase 3 Trial of Chinese COVID-19 Vaccine


Source: voanews.com voanews.com

Key Topics in this News Article:

News Snapshot:

Pakistan began final-phase testing Tuesday of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation. Officials at the National Health Institute (NIH) said that China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement. NIH chief Major General Dr. Aamer Ikram told a nationally televised news conference that thousands of volunteers will be enrolled and administered the vaccine for the phase-3 study being undertaken at several major hospitals across Pakistan. “We are expecting...